Detalhe da pesquisa
1.
PHF6-altered T-ALL Harbor Epigenetic Repressive Switch at Bivalent Promoters and Respond to 5-Azacitidine and Venetoclax.
Clin Cancer Res
; 30(1): 94-105, 2024 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37889114